Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2005
03/17/2005WO2005024051A1 Cell-based assay for identifying peptidase inhibitors
03/17/2005WO2005024031A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005WO2005024027A1 Antibody drug
03/17/2005WO2005024001A2 Ferment activator based on lactic acid bacteria, and method of preparing a product using said activator
03/17/2005WO2005024000A1 Methods for producing recombinant proteins
03/17/2005WO2005023998A1 Construction of new xylose utilizing saccharomyces cerevisiae strain
03/17/2005WO2005023997A1 Novel microorganism and method of treating organic solid matters with the use of the microorganism
03/17/2005WO2005023990A2 Trans-splicing mediated photodynamic therapy
03/17/2005WO2005023850A2 Method for producing inosine and 5'-inosinic acid by fermentation using bacterium belonging to the genus escherichia
03/17/2005WO2005023205A2 Compositions and methods for yersinia pestis treatment
03/17/2005WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen
03/17/2005WO2005023005A1 Biocontrol of xylella fastidiosa
03/17/2005WO2005003310A3 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast
03/17/2005WO2005002643A3 Method and products for delivering biological molecules to cells using multicomponent nanostructures
03/17/2005WO2005000008A3 Method for in vitro production of mycorrhizal fungi mycocallus and mycorrhized biological support obtained thus
03/17/2005WO2004085607A3 Texturizing lactic bacteria
03/17/2005WO2004081166A3 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine
03/17/2005WO2004074461A3 Production of modified glycoproteins having multiple antennary structures
03/17/2005WO2003016489A8 Porcine leptin protein, antisense and antibody
03/17/2005WO2002100530A8 Method for controlling fermentation
03/17/2005US20050060773 Expression vector comprising nucleotide sequences coding gene associated with plant dwarfing (RHT) for use as tool in establishing seedling development in plants
03/17/2005US20050060770 Antifungal proteins
03/17/2005US20050060767 DNA shuffling to produce herbicide selective crops
03/17/2005US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering
03/17/2005US20050059803 Oligonucleotide probe for use in detection of phosphatidyl inositol 3 kinase expression; fungicides; antitumor agents
03/17/2005US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation
03/17/2005US20050059725 Treating schizophrenia or Parkinson's disease with thiolutin dioxide
03/17/2005US20050059633 Novel glucans and novel glucansucrases derived from lactic acid bacteria
03/17/2005US20050059577 Glycosylphosphatidylinositol containing polypeptides
03/17/2005US20050059136 Pyruvate producing yeast strain
03/17/2005US20050059134 Fermentative production of lycopene by blakeslea trispora
03/17/2005US20050059133 Hydrolase comprising reduced immunogenicity for use as diagnostic and therapeutic tool in cancer treatment; immunotherapy; tissue targeted therapy
03/17/2005US20050059130 Lipolytic enzyme variants
03/17/2005US20050059124 Using trangenic gramnegative bacteria exhibiting an overexpression of succinyl-CoA synthetase (SUC) as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds
03/17/2005US20050059122 Targeted carrier fusions for delivery of chemotherapeutic agents
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders
03/17/2005US20050059112 Proteases from gram-positive organisms
03/17/2005US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes
03/17/2005US20050059082 Method for producing protein libraries and for selecting proteins from said libraries
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050059076 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/17/2005US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use
03/17/2005US20050059050 Novel human ion-exchanger proteins and polynucleotides encoding the same
03/17/2005US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders
03/17/2005US20050059030 Using oligonucleotide probes comprising ribosomal sequence as tool in detection of methicillin resistant strains of bacteria; single nucleotide polymorphism
03/17/2005US20050059004 Nucleotide sequences coding translational regulatory element comprising adenine rich regions for use in activation of cap-independent translation of a nucleotide sequence of interest in eukaryotic cells or organisms; translation and heterologous gene expression
03/17/2005US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
03/17/2005US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy
03/17/2005US20050058982 Modified small interfering RNA molecules and methods of use
03/17/2005US20050058667 Adjuvants for use in vaccines
03/17/2005US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor
03/17/2005US20050058660 Novel surface antigen
03/17/2005US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050056152 Solid fermentation starter having improved storage stability
03/17/2005CA2538028A1 Apparatus for ultrasonic microbial disruption
03/17/2005CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005CA2536099A1 Partitioning of recombinant proteins into e.coli supernatant or periplasm
03/17/2005CA2535653A1 Novel microorganism and method of treating organic solid matters with the use of the microorganism
03/17/2005CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen
03/16/2005EP1514941A2 Paraquat resistance gene and a vascular tissue- and trichome-specific promotor
03/16/2005EP1514940A1 Chondroitin synthetase and dna coding for the enzyme
03/16/2005EP1514939A1 Chondroitin synthetase and nucleic acid coding for the enzyme
03/16/2005EP1514938A1 Heat-resistant DNA ligase
03/16/2005EP1514936A2 A novel method to isolate mutants and to clone the complementing gene
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514933A1 Secretory protein or membrane protein
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514926A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof
03/16/2005EP1514925A1 Method of screening compound affecting amyloid beta production
03/16/2005EP1514924A1 Novel acylase gene
03/16/2005EP1514921A2 Method for producing L-threonine
03/16/2005EP1514876A2 Antibody against prostate stem cell antigen (PSCA)
03/16/2005EP1514553A1 Lactic acid bacteria powder double-coated using protein and polysaccharide and method preparing the same and a dosage form thereof
03/16/2005EP1514216A2 Generation and selection of protein library in silico
03/16/2005EP1513946A1 POLYPEPTIDES HAVING a- H-a-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
03/16/2005EP1513941A2 Preparation of microbial oil containing polyunsaturated fatty acids
03/16/2005EP1513940A2 Methods and materials for the production of lactic acid in yeast
03/16/2005EP1513939A2 Fermentation process using specific oxygen uptake rates as a process control
03/16/2005EP1513937A2 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein
03/16/2005EP1513931A2 Modified phytases
03/16/2005EP1513925A2 Streptococcus thermophilus strain producing exopolysaccharide
03/16/2005EP1513924A1 Attenuated listeria spp. and methods for using the same
03/16/2005EP1513923A2 Methods and materials for the production of d-lactic acid in yeast
03/16/2005EP1513922A1 Pasteurisation process for microbial cells and microbial oil
03/16/2005EP1513879A2 Synthetic antibody phage libraries
03/16/2005EP1513876A2 Human 5-ht7 receptor promoter sequence
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513550A2 Novel bacterium for treatment of disease
03/16/2005EP1513545A2 Methods and means to promote gut absorption
03/16/2005EP1318824B1 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
03/16/2005EP1282688B1 Ammonia-oxidizing bacteria
03/16/2005EP0952772B1 Methods of use of mononuclear phagocytes to promote axonal regeneration
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005EP0763127B1 Deblocking the common pathway of aromatic amino acid synthesis
03/16/2005CN1596312A Antibiotics GE 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
1 ... 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 ... 1489